- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06336967
Testing a Wellness App for First Responders, Military Personnel and Veterans
A Randomized Controlled Trial of a Wellness App for First Responders, Military Personnel and Veterans
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19146
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Law enforcement, military personnel, or veteran.
- Employed (part-time, full-time, self-employed).
- Owns compatible smartphone.
- Not paid by the GUIDE App/Nlyten Corp.
- No previous use of GUIDE App.
Exclusion Criteria:
- Not law enforcement, military personnel, or veteran.
- Not employed.
- Paid by GUIDE App/Nlyten Corp.
- Previous use of GUIDE App.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: GUIDE with incentives
Immediate access to the GUIDE App smartphone application for 4 weeks with the opportunity to earn additional compensation, up to $100 in total, based on app engagement.
|
The GUIDE App is a wellbeing app designed for first responders and veterans that uses small group support, a learning management system, drivers of behavior change, and an anonymous member experience safeguarded by a leader in identity and login privacy, Okta (okta.com).
It includes three main features: 1) Community, 2) Wisdom, and 3) Daily Practice.
The Community feature connects app users with an online community of like folks, allowing for human support, encouragement, accountability and coaching.
Online communities are moderated by GUIDE employees.
The Wisdom feature includes tools and interactive media for personal growth.
The Daily Practice feature includes simple, daily routines to maintain mental and emotional wellness.
|
|
Experimental: GUIDE without incentives
Immediate access to the GUIDE App for 4 weeks without the opportunity to earn additional compensation.
|
The GUIDE App is a wellbeing app designed for first responders and veterans that uses small group support, a learning management system, drivers of behavior change, and an anonymous member experience safeguarded by a leader in identity and login privacy, Okta (okta.com).
It includes three main features: 1) Community, 2) Wisdom, and 3) Daily Practice.
The Community feature connects app users with an online community of like folks, allowing for human support, encouragement, accountability and coaching.
Online communities are moderated by GUIDE employees.
The Wisdom feature includes tools and interactive media for personal growth.
The Daily Practice feature includes simple, daily routines to maintain mental and emotional wellness.
|
|
No Intervention: Waitlist
Waitlisted with delayed access to the GUIDE App without the opportunity to earn additional compensation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PERMA-Profiler Overall Wellbeing Score
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PERMA-Profiler is designed to measure the general wellbeing of adults; specifically this questionnaire measures positive and negative emotions, engagement, relationships, meaning, accomplishment, and health.
Participants respond to 23 items on an 11-point Likert scale, from 0 to 10. Scores are calculated as the average of the items comprising each factor.
Lower scores indicate lower flourishing, and higher scores indicate higher flourishing.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Patient Health Questionnaire for Depression Symptoms (PHQ-8)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PHQ-8 is a self-reported measure of depressive symptoms composed of 8 Likert type items with a response scale ranging from 0 (Not at all) to 3 (Nearly every day), that refer to the presence of that symptom during the previous 2 weeks.
Each item corresponds to the first 8 symptoms of the 4th edition of the DSM-IV diagnostic criteria for major depressive disorder.
The PHQ-8 final score is obtained by adding the score for each of the items, ranging from 0 to 24 (higher scores corresponding to higher levels of depression).
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Generalized Anxiety Disorder (GAD-7)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
GAD-7 consists of seven items measuring worry and anxiety symptoms.
Each item is scored on a four-point Likert scale (0-3) with total scores ranging from 0 to 21 with higher scores reflecting greater anxiety severity.
Scores above 10 are considered to be in the clinical range.
The GAD-7 has shown good reliability and construct validity.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
WHO Well-being Index (WHO-5)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The World Health Organisation- Five Well-Being Index (WHO-5) is a short self-reported measure of current mental wellbeing. The WHO-5 consists of five statements, which respondents rate according to the scale below (in relation to the past two weeks). All of the time = 5 Most of the time = 4 More than half of the time = 3 Less than half of the time = 2 Some of the time = 1 At no time = 0. The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being. |
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Personal Wellbeing Score (PWS)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The Personal Wellbeing Score (PWS) is based on the Office of National Statistics (ONS) four subjective well-being questions (ONS4) and thresholds.
It evaluates life satisfaction, sense of purpose, happiness, and anxiety.
Each PWS item is scored as follows: Disagree=0, Neutral=1, Agree=2 and Strongly Agree=3.
Summary scores are calculated by aggregating all items and transforming to a scale of 0 to 100, with higher scores indicating greater well-being.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Difficulties in Emotion Regulation Scale Short Form (DERS-SF)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The Difficulties in Emotion Regulation Scale Short Form (DERS-SF) is an 18-item measure used to identify emotional regulation issues in adults.
The measure uses 6 subscales to measure 4 dimensions of emotional regulation: awareness; acceptance; the ability to engage in goal-directed behavior and refrain from impulsive behavior when experiencing negative emotions; and access to emotion regulation strategies perceived as effective.
Respondents indicate how often each statement applies to them on a 5 point scale, where 1=Almost Never (0-10%), 2=Sometimes (11-35%), About Half of the Time (36-65%), Most of the Time (66-90%), Almost Always (91-100%).
Scores range from 18 to 90, with higher scores indicating greater difficulties in emotion regulation.
The DERS-SF Total Score is computed by summing responses across all items.
Lower scores represent better emotion regulation outcomes.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (SUS)
Time Frame: 4 weeks post-trial
|
The System Usability Scale (SUS) measures perceptions of usability of a given system, in this case, the GUIDE App.
The scale consists of 10 items, each rated on a 5-point Likert Scale from 1 ("Strongly disagree") to 5 ("Strongly agree").
Responses are transformed to get a total range of possible values from 0-100, with higher scores indicating higher perceptions of usability.
Typically, a score above 68 is regarded as a good score.
|
4 weeks post-trial
|
|
Positive Emotion (Positive Emotion Subscale of the PERMA-Profiler)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PERMA-Profiler is a 23-item measure that assesses wellbeing across five domains (positive emotion, engagement, relationships, meaning, accomplishment).
The instrument was constructed so that each domain can be defined and measured as separate but correlated constructs.
This study will use the Positive Emotion subscale of the PERMA.
This subscale includes 3 items on an 11-point Likert scale, from 0 to 10. Scores are calculated as an average of these items, with lower scores indicating less positive emotion and high scores indicating more positive emotion.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Social Connectedness (Engagement Subscale of PERMA-Profiler)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PERMA-Profiler is a 23-item measure that assesses wellbeing across five domains (positive emotion, engagement, relationships, meaning, accomplishment).
The instrument was constructed so that each domain can be defined and measured as separate but correlated constructs.
This study will use the Engagement and Relationship subscales of the PERMA.
These subscales include 3 items each, ranked on an 11-point Likert scale, from 0 to 10. Scores are calculated as an average of these items for each subscale, with lower scores indicating less flourishing in respect to engagement/relationships and high scores indicating better engagement/relationships.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Social Connectedness (Relationship Subscale of PERMA-Profiler)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PERMA-Profiler is a 23-item measure that assesses wellbeing across five domains (positive emotion, engagement, relationships, meaning, accomplishment).
The instrument was constructed so that each domain can be defined and measured as separate but correlated constructs.
This study will use the Engagement and Relationship subscales of the PERMA.
These subscales include 3 items each, ranked on an 11-point Likert scale, from 0 to 10. Scores are calculated as an average of these items for each subscale, with lower scores indicating less flourishing in respect to engagement/relationships and high scores indicating better engagement/relationships.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Personal Growth (Meaning Subscale of the PERMA-Profiler)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PERMA-Profiler is a 23-item measure that assesses wellbeing across five domains (positive emotion, engagement, relationships, meaning, accomplishment).
The instrument was constructed so that each domain can be defined and measured as separate but correlated constructs.
This study will use the Meaning and Accomplishment subscales of the PERMA.
These subscales include 3 items each, ranked on an 11-point Likert scale, from 0 to 10. Scores are calculated as an average of these items for each subscale, with lower scores indicating less flourishing in respect to meaning/accomplishment and high scores indicating more meaning/accomplishment.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Personal Growth (Accomplishment Subscale of the PERMA-Profiler)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The PERMA-Profiler is a 23-item measure that assesses wellbeing across five domains (positive emotion, engagement, relationships, meaning, accomplishment).
The instrument was constructed so that each domain can be defined and measured as separate but correlated constructs.
This study will use the Meaning and Accomplishment subscales of the PERMA.
These subscales include 3 items each, ranked on an 11-point Likert scale, from 0 to 10. Scores are calculated as an average of these items for each subscale, with lower scores indicating less flourishing in respect to meaning/accomplishment and high scores indicating more meaning/accomplishment.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Utrecht Work Engagement Scale (UWES-17)
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The Utrecht Work Engagement Scale-17 assesses work engagement, or a positive, fulfilling, work-related state of mind characterized by vigor, dedication, and absorption.
It is intended to measure the 'opposite' of burnout in both university students and employees.
Items were developed to reflect three underlying dimensions: "Vigor" (VI); "Dedication" (DE), and "Absorption" (AB).
The subscales were found to be internally consistent but relatively strongly correlated.
Items are scored along a 6-point Likert-type scale (0 = Never to 6 = Always or Every day).
Scores are calculated by summing item scores.
The total score ranges from 0 to 102 points.
A higher score indicates greater worker engagement.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Maslach Burnout Inventory (MBI) - Emotional Exhaustion
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The Maslach Burnout Inventory - Emotional Exhaustion (MBI-EE) is a validated self-report measure assessing feelings of emotional depletion and fatigue due to work-related stress.
It is part of the Maslach Burnout Inventory (MBI), which evaluates burnout across three domains.
Scores range from 0 to 54, with higher scores indicating greater emotional exhaustion.
The Emotional Exhaustion Score is computed by summing responses to nine Likert-type items.
Lower scores represent better well-being outcomes.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Maslach Burnout Inventory (MBI) - Personal Accomplishment
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The Maslach Burnout Inventory - Personal Accomplishment (MBI-PA) is a validated self-report measure assessing feelings of competence and achievement in one's work.
It is part of the Maslach Burnout Inventory (MBI), which evaluates burnout across three domains.
Scores range from 0 to 48, with higher scores indicating greater personal accomplishment and lower scores suggesting burnout-related inefficacy.
The Personal Accomplishment Score is computed by summing responses to eight Likert-type items.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Maslach Burnout Inventory (MBI) - Depersonalization
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
The Maslach Burnout Inventory - Depersonalization (MBI-DP) is a validated self-report measure assessing feelings of detachment and impersonal responses toward others in a work setting.
It is part of the Maslach Burnout Inventory (MBI), which evaluates burnout across three domains.
Scores range from 0 to 30, with higher scores indicating greater depersonalization and emotional distancing.
The Depersonalization Score is computed by summing responses to five Likert-type items.
Lower scores represent better well-being outcomes.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Number of Participants Still Employed
Time Frame: assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
Whether the participant still has their job at the end of the 4-week trial period.
|
assessed at Baseline and post-trial (over 4 weeks), post-trial (week 4) reported
|
|
Feasibility of Intervention Measure (FIM)
Time Frame: assessed at post-trial (4 weeks)
|
The Feasibility of Intervention Measure (FIM) is used to measure the feasibility of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the average of the items, ranging from 1 to 5, with higher scores indicating greater feasibility of the intervention.
|
assessed at post-trial (4 weeks)
|
|
Acceptability of Intervention Measure (AIM)
Time Frame: 4 weeks post-trial
|
The Acceptability of Intervention Measure (AIM) is used to measure the acceptability of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the average of the items, ranging from 1 to 5, with higher scores indicating greater acceptability of the intervention.
|
4 weeks post-trial
|
|
Intervention Appropriateness Measure (IAM)
Time Frame: 4 weeks post-trial
|
The Intervention Appropriateness Measure (IAM) is used to measure the appropriateness of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the average of the items, ranging from 1 to 5, with higher scores indicating greater appropriateness of the intervention.
|
4 weeks post-trial
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Intervention Measure (FIM)
Time Frame: 4 weeks post-trial
|
The Feasibility of Intervention Measure (FIM) is used to measure the feasibility of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the sum of the items, ranging from 5 to 20, with higher scores indicating greater feasibility of the intervention.
|
4 weeks post-trial
|
|
Acceptability of Intervention Measure (AIM)
Time Frame: 4 weeks post-trial
|
The Acceptability of Intervention Measure (AIM) is used to measure the acceptability of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the sum of the items, ranging from 5 to 20, with higher scores indicating greater acceptability of the intervention.
|
4 weeks post-trial
|
|
Intervention Appropriateness Measure (IAM)
Time Frame: 4 weeks post-trial
|
The Intervention Appropriateness Measure (IAM) is used to measure the appropriateness of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the sum of the items, ranging from 5 to 20, with higher scores indicating greater appropriateness of the intervention.
|
4 weeks post-trial
|
|
System Usability Scale (SUS)
Time Frame: 4 weeks post-trial
|
The System Usability Scale (SUS) measures perceptions of usability of a given system, in this case, the GUIDE App.
The scale consists of 10 items, each rated on a 5-point Likert Scale from 1 ("Strongly disagree") to 5 ("Strongly agree").
Responses are transformed to get a total range of possible values from 0-100, with higher scores indicating higher perceptions of usability.
Typically, a score above 68 is regarded as a good score.
|
4 weeks post-trial
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Heather J Nuske, PhD, University of Pennsylvania
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 855282
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Wellness
-
Indiana UniversityCommunity Health Network; Boys & Girls Clubs of IndianapolisCompletedMental Health Wellness 1 | Child Behavior | Adolescent Behavior | Mental Health Wellness 2United States
-
Cedars-Sinai Medical CenterNot yet recruitingMental Health Wellness 1 | Wellness, PsychologicalUnited States
-
Rutgers, The State University of New JerseyRecruitingMental Health Wellness 1 | Occupational Problems | Mental Health Wellness 2United States
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Transcultural Psychosocial Organization NepalKing's College LondonRecruitingMental Health WellnessNepal
-
Hospital Miguel ServetActive, not recruitingMental Health WellnessSpain
-
Wake Forest University Health SciencesCompleted
-
Fonterra Research CentreSun GenomicsCompleted
-
City University of Hong KongStanford University; Harvard UniversityCompletedMental Health WellnessColombia, Indonesia, South Africa, Ukraine
-
Fonterra Research CentreCompleted
Clinical Trials on GUIDE
-
Cairo UniversityUnknownEndodontic Disease | Endodontic Re-treatment Failure
-
Clinica Universidad de Navarra, Universidad de...CompletedAnaphylactic ReactionSpain
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
Xiamen Cardiovascular Hospital, Xiamen UniversityRecruiting
-
Cairo UniversityActive, not recruitingVertical Deficeny of Posterior MandibleEgypt
-
Tanta UniversityEnrolling by invitationImmediate Implant Placement in Maxillary Molar RegionEgypt
-
Cairo UniversityUnknown
-
Changhai HospitalTerminatedThrombosis | Acute Ischemic Stroke | Large Vessel Occlusion | ThrombectomyChina
-
Capital Medical UniversityUnknownStroke | Mechanical Thrombectomy | Balloon Guide CatheterChina
-
Isfahan University of Medical SciencesCompletedUreteral CalculiIran, Islamic Republic of